EBIT: Income before interest and taxes.
Dare Bioscience, Inc. (DARE) had EBIT of $-2.97M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.19M |
|
$-2.98M |
|
$0.32M |
|
$-0.13M |
|
$3.16M |
|
$-2.97M |
|
$-0.01M |
|
$-2.98M |
|
$-2.98M |
|
$-2.98M |
|
$-2.98M |
|
$-2.98M |
|
$-2.98M |
|
|
EBIT |
$-2.97M |
$-2.40M |
|
14.89M |
|
14.89M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$16.69M |
|
$1.42M |
|
$5.68M |
|
$22.37M |
|
$16.92M |
|
-- |
|
$6.01M |
|
$22.93M |
|
$-0.56M |
|
$-0.56M |
|
$-0.56M |
|
15.17M |
|
| Cash Flow Statement Financials | |
$-12.30M |
|
$-0.08M |
|
$0.24M |
|
$25.01M |
|
$12.92M |
|
$-12.09M |
|
$0.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.99 |
|
-- |
|
-- |
|
-- |
|
-0.27 |
|
-70.57% |
|
-1582.54% |
|
-1582.54% |
|
-- |
|
-1590.42% |
|
-1590.42% |
|
$-12.38M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.41 |
|
219.03 |
|
531.81% |
|
532.54% |
|
-13.33% |
|
532.54% |
|
$-0.04 |
|
$-0.83 |
|
$-0.83 |
|